Markets
Eli Lilly’s Valuation: Blockbuster Drug vs. Top Analyst Picks
Eli Lilly benefits from a blockbuster weight loss drug, yet The Motley Fool Stock Advisor did not include LLY in its top...
#motley fool 6 articles
Markets
Mercado Libre Excluded From Top 10 Stock Picks by Prominent Analyst Team
Mercado Libre, often dubbed the 'Amazon of Latin America,' was notably absent from The Motley Fool Stock Advisor's recent list of 10...
Markets
TopBuild Stock: Expert Ratings and Investment Outlook
Motley Fool analysts weigh in on TopBuild (BLD) stock, offering insights into its potential as an investment opportunity. Expert ratings and market...
Markets
MP Materials Q1 2026 Transcript Published by Motley Fool
The Q1 2026 earnings transcript for MP Materials (MP) was published on May 7, 2026, by Motley Fool Transcribing, providing insights for...
Markets
Index Funds vs. Active Management: Expert Guidance on Investment Choices
Motley Fool experts Robert Brokamp and Stephanie Marini dissect the pros and cons of index funds and actively managed funds, offering insights...
Markets
Four Key Rules for Social Security Survivor Benefits You Need to Know
Understanding Social Security survivor benefits is crucial for financial planning. Learn about strategic claiming, remarriage rules, divorced spouse rights, and the earnings...